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There is neither statistically significant difference between the rate of positive samples in SP
and AS (chi2 test) nor in the different age categories (Kolmogorov-Smirnov test).
Average viral load values were higher for GI NoV in SP than in AP (p=0.02), when they were
higher for GII NoV in AP than in SP (p=0.04) (Table IV).
Molecular epidemiology of norovirus in 
symptomatic and asymptomatic 
population in Burkina Faso
The purpose of this epidemiological study was to determine the prevalence of NoV
infection in the area of Bobo Dioulasso (Southern part of Burkina Faso) by molecular
diagnosis methods in patients presenting or not gastroenteritis symptoms, to quantify the
excreted viral load, and to genotype the circulating strains.
Patients with and without gastro-intestinal disorders were selected in several Health Care
Centres of Bobo Dioulasso (Fig.2) and during a campaign against malnutrition (Fig.3).
Clinical and epidemiological data, as well as stool samples (n=453), were collected during
8 weeks through March to April 2011.
Fig1. Geographical regions of Burkina Faso 
(source: www.guidemondialdevoyage.com)
Noroviruses (NoV), belonging to the family Caliciviridae, are
now recognized as the leading cause of gastroenteritis
outbreaks worldwide, and represent an important cause of
sporadic gastroenteritis in both children and adults.
Many studies describe NoV epidemiology. However, few data
are available about the NoV strains circulating in most of
African countries, in particular in Burkina Faso. The population
of Burkina Faso is characterized by the young age of its
habitants, and most are living in rural environment.
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Patients Total Negative Positive GI/IV GII Mixed
SP 319 252 67 23 34 10
AP 134 67 31 15 14 2
Total 453 355 98 38 48 12
Table III. Results of norovirus detection and genogrouping by real time RT-PCR in stool samples of symptomatic (SP) and asymptomatic patients (AP) from Bobo
Dioulasso (Burkina Faso).
Fig 4. Repartition of the NoV genogroups detected by real time RT-PCR among the different age categories in symptomatic (A) et asymptomatic (B) patients from
Bobo Dioulasso (Burkina Faso).
Viral load (copies/ml) (*)
N Samples Average value Min Max
SP
GI/IV 33 3 053 564 16.2 46 300 000
GII 44 177 376 <10 5 104 758
AP
GI/IV 17 191 397 11.8 1 764 338
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Phylogenic analysis showed a high degree of genotypical diversity in both groups of patients
(Fig.5).
One recombinant strain GII.7/GII.6 was also detected, to our knowledge, for the first time
(Fig.6).
Viral genomic RNA was automatically extracted with a Maxwell® (Promega) instrument.
Molecular detection of genogroups (G) I, II and IV NoV in stool samples was performed by
a home-made real-time RT-PCR (1), targeting the ORF1-ORF2 polymerase junction region.
For each positive sample, viral load was estimated by using standard curves (successive
dilutions of recombinant GI and GII plasmids). Molecular characterization was performed
on 27 detected strains, using both polymerase and capsid regions.
Even if a true pathogenic role of NoV could not be shown from the study design, it allowed to
precise the molecular epidemiology of NoV strains prevalent in a representative country of
the East African region. It also showed that asymptomatic patients could play an important
role as a NoV “reservoir”. Despite the fact that GII strains, and more precisely those
belonging to GII.4 genotype, are nowadays highly reported worldwide, the surprising
proportion of NoV GI detected in this study suggests that GI and GII strains should be
excreted in equal proportion in the environment. The origin of this epidemiologic difference,
even if partially explained by the difference in immunity and genetic sensitivity of the
population, is still to be solved.
Fig.2: Health Care Centres of Bobo Dioulasso.
1: Dô ; 2: Colma ; 3: Accartville ; 4: Colsama ; 5: Belleville. Fig.3: Campaign against malnutrition, Colsama (photo: C.Martin)
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0-6 m 24 3 0.89
7-12 m 75 13 0.85
13-36 m 116 45 0.72
3-5 y 65 62 0.51
6-10 y 13 2 0.87
>11 y (11-68y) 26 9 0.74
Sex
Male 146 56 0.72
Female 173 78 0.69
Health Care Centre
Colsama 101 53 0.68
Belleville 142 81 0.63
Accart Ville 38 0 1
Colma 34 0 1
Dô 4 0 1
Table I: Epidemiological data for the symptomatic (SP) and the asymptomatic patients (AP).
Table II: Frequency of reported symptoms in the symptomatic patients.
Symptoms N %
Diarrhoea 319 100
Abdominal pain 138 43
Fever 88 28
Vomits 64 20
Muscular pain 57 18
Shiver 39 12
Molecular detection of NoV and genogrouping
Most of the selected patients in both symptomatic
(SP) and asymptomatic patients (AP) were younger
than 10 years, representing 91.9 and 93.3%
respectively (Table I).
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NoV were detected in 21.6% of the 453 collected stool samples, with a distribution of
21.0% and 23.1% in the samples from the 319 symptomatic and the 134 asymptomatic
patients respectively.
Genogroup distribution was 34.3% for GI, 50.7% for GII and 15% for both GI and GII
among SP’s samples, and was 48.4% for GI, 45.2% for GII and 6.4% for both GI and GII
among AP’s samples (Table III).
GII 16 890 641 12.1 13 300 000 (*) 95% confidence interval
Figure 6. Sliding window nucleotide identity plot of a partial coding region for
the RNA-dependent RNA polymerase (3' end of open reading frame 1) and
the 5' extremity of ORF2 coding the single capsid protein of the Hu/NV/
T209/11/BF genome compared with GII.6 (Hu/NV/SU16/97/JP, gi: AB039778)
and GII.7 (Hu/NV/SU4/96/JP, gi: AB020556) reference strains. Analysis
performed with the Simplot software. Nucleotide positions are reported on
























Fig 5. Distribution of NoV genotypes in stool samples of 12 symptomatic
and 7 asymptomatic patients from Bobo Dioulasso (Burkina Faso)
obtained from PCR performed on the polymerase region.
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